Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

Altogether, 159,572 candidates are appearing in the morning and evening shifts of the exams at 175 examination centres, of ...

Shareholder/Analyst Call April 29, 2026 10:30 AM EDTCompany ParticipantsGail MandelSteve Milton - Corporate SecretaryKurt Ekert ...

Good afternoon, and welcome to the MGM Resorts International First Quarter 2026 Earnings Conference Call. Joining the call from the company today are Bill Hornbuckle, Chief Executive Officer and ...

Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma — its most dangerous form — is also ...

Kentucky’s horsemen and regulators are clashing as scratch rates rise; available statistics offer hints as to how effective ...

John Marshall Bancorp, Inc. (Nasdaq: JMSB) (the "Company"), today announced that its Board of Directors has declared a quarterly cash dividend of $0.09 for each share of its common stock outstanding.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

Filing incorrect details in statutory forms attracts penalties even if later corrected. The key takeaway is that ...

Zurich, 29 April 2026 – UBS Group AG today reported its first-quarter results 2026 on a consolidated basis. These reports are available for download on the UBS website.

Glenstar Minerals Inc. (FRA: VO20) ("Glenstar" or the "Company") announces that the Phase 1 reverse circulation drill program at the Company's Wildhorse Project in Mineral County, Nevada, (see news ...

Wesley Taylor and Taeyoon Choi are the dual Detroit fellows, alongside Miguel Novelo and Rhonda Holberton, both of San Jose, and the collaborative duo LIZN’BOW of Miami.